---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-22-001014"
form_type: "8-K"
ticker: "ARCT"
cik: "0001768224"
company_name: "Arcturus Therapeutics Holdings Inc."
filed_at: "2022-06-24T23:59:59+00:00"
generated_at: "2026-06-24T23:21:13.644202+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Arcturus stockholders approve 3.75M share increase to equity plan, raise director compensation caps

## Summary
- Stockholders approved amending 2019 Omnibus Equity Incentive Plan to add 3,750,000 shares of common stock.
- Annual director award limit raised from $500K to $2M for new directors, lead independent director, and non-employee chair; $1M for others.
- Plan amendment passed with 9,375,429 votes for, 8,044,751 against, and 286,830 abstentions (44.7% opposed).
- Directors elected, say-on-pay approved, and Ernst & Young ratified as auditor for fiscal 2022.
- Stockholders voted for an annual say-on-frequency vote; Board adopted every-year frequency.

## SEC filing metadata
- accession: 0001193805-22-001014
- form_type: 8-K
- ticker: ARCT
- cik: 0001768224
- company_name: Arcturus Therapeutics Holdings Inc.
- filed_at: 2022-06-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1768224/000119380522001014/0001193805-22-001014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1768224/000119380522001014/e621778_8k-arct.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-22-001014
- JSON: https://secwatch.observer/filing/0001193805-22-001014.json
- Plain text: https://secwatch.observer/filing/0001193805-22-001014.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.